Tahani Nasser Altamimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tahani Nasser Altamimi has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
Fahmida Khatoon
Department of Biochemistry, College of Medicine, University of Hail, Hail 2240, Saudi Arabia
3 shared publicationsFatimah Fahad Alreshidi
2 shared publicationsFauzia Ashfaq
Clinical Nutrition Department, Applied Medical Sciences College, Jazan University, Jazan 82817, Saudi Arabia
2 shared publicationsMohammad Idreesh Khan
Department of Clinical Nutrition, College of Applied Health Sciences in Ar Rass, Qassim University, Ar Rass 51921, Saudi Arabia
2 shared publications- Mohd Saleem
Department of Pathology, College of Medicine, University of Hail, Hail 55476, Saudi Arabia
2 shared publications Rana Aboras
2 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by Springer Nature in BMC Geriatrics
Impact of telemedicine on minimizing polypharmacy in older adult patients receiving primary care: a systematic review
- 19 September 2026
- Published by Springer Nature in BMC Geriatrics
Open AccessImpact of telemedicine on minimizing polypharmacy in older adult patients receiving primary care: a systematic review
- 17 February 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 104 (2) , 488-497
Dementia prevalence within the Kingdom of Saudi Arabia National Guard Health System (2015–2023): An exploratory epidemiological study
Background: Dementia is recognized as one of the prevalent neurocognitive disorders among older adults in Saudi Arabia, yet research efforts on its prevalence remains limited and fragmented, making it difficult to gain a full understanding of its epidemiology. Objective: To explore dementia epidemiology and associated data within the older population in the sector of National Guard Health System (NGHS), Saudi Arabia. Methods: This was a multicenter study that utilized medical records from NGHS centers across the country. We included data from all individuals aged 50 years and older who sought medical care between January 1, 2015, and January 1, 2023. Results: Nearly half of the study's participants were men (51.9%), with the majority being diagnosed between the ages of 70–79 years (38.5%) and 80–89 years (31%). Dementia was identified in 3.37% of participants. The most prevalent subtype was late-onset Alzheimer's disease (35.6%), followed by unspecified dementia (18.4%). Significant differences between genders were observed, particularly in the age at diagnosis (p = 0.003) and the prevalence of ischemic strokes as a risk factor (p < 0.001). Conclusions: In this multicenter study utilizing the NGHS cohort, Alzheimer's disease emerged as the most prevalent subtype of dementia. This research has the potential to influence clinical practices by enhancing the early identification and management of dementia and provides a solid foundation for developing evidence-based policy strategies to tackle the increasing challenges of dementia in Saudi Arabia.
- 17 February 2025
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 104 (2) , 488-497
Dementia prevalence within the Kingdom of Saudi Arabia National Guard Health System (2015–2023): An exploratory epidemiological study
Background: Dementia is recognized as one of the prevalent neurocognitive disorders among older adults in Saudi Arabia, yet research efforts on its prevalence remains limited and fragmented, making it difficult to gain a full understanding of its epidemiology. Objective: To explore dementia epidemiology and associated data within the older population in the sector of National Guard Health System (NGHS), Saudi Arabia. Methods: This was a multicenter study that utilized medical records from NGHS centers across the country. We included data from all individuals aged 50 years and older who sought medical care between January 1, 2015, and January 1, 2023. Results: Nearly half of the study's participants were men (51.9%), with the majority being diagnosed between the ages of 70–79 years (38.5%) and 80–89 years (31%). Dementia was identified in 3.37% of participants. The most prevalent subtype was late-onset Alzheimer's disease (35.6%), followed by unspecified dementia (18.4%). Significant differences between genders were observed, particularly in the age at diagnosis (p = 0.003) and the prevalence of ischemic strokes as a risk factor (p < 0.001). Conclusions: In this multicenter study utilizing the NGHS cohort, Alzheimer's disease emerged as the most prevalent subtype of dementia. This research has the potential to influence clinical practices by enhancing the early identification and management of dementia and provides a solid foundation for developing evidence-based policy strategies to tackle the increasing challenges of dementia in Saudi Arabia.
- Open Access
- 9 January 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (2)
Prevalence and Molecular Characterization of Carbapenemase-Producing Multidrug-Resistant Bacteria in Diabetic Foot Ulcer Infections
Background: Diabetic foot ulcers (DFUs) represent severe complications in diabetic patients, often leading to chronic infections and potentially resulting in nontraumatic lower-limb amputations. The increasing incidence of multidrug-resistant (MDR) bacteria in DFUs complicates treatment strategies and worsens patient prognosis. Among these pathogens, carbapenemase-producing pathogens have emerged as particularly concerning owing to their resistance to β-lactam antibiotics, including carbapenems. Methods: This study evaluated the prevalence of MDR bacteria, specifically carbapenemase-producing pathogens, in DFU infections. A total of 200 clinical isolates from DFU patients were analyzed via phenotypic assays, including the modified Hodge test (MHT) and the Carba NP test, alongside molecular techniques to detect carbapenemase-encoding genes (blaKPC, blaNDM, blaVIM, blaIMP, and blaOXA-48). Results: Among the isolates, 51.7% were confirmed to be carbapenemase producers. The key identified pathogens included Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Escherichia coli. The most commonly detected carbapenemase genes were blaKPC (27.6%) and blaNDM (24.1%). Carbapenemase-producing isolates presented high resistance to β-lactam antibiotics, whereas non-carbapenemase-producing isolates presented resistance through mechanisms such as porin loss and efflux pumps. Conclusions: The findings of this study highlight the significant burden of MDR infections, particularly carbapenemase-producing organisms, in DFUs. MDR infections were strongly associated with critical clinical parameters, including pyrexia (p = 0.017), recent antibiotic use (p = 0.003), and the severity of infections. Notably, the need for minor amputations was much higher in MDR cases (p < 0.001), as was the need for major amputations (p < 0.001). MDR infections were also strongly associated with polymicrobial infections (p < 0.001). Furthermore, Wagner ulcer grade ≥II was more common in MDR cases (p = 0.002). These results emphasize the urgent need for enhanced microbiological surveillance and the development of tailored antimicrobial strategies to combat MDR pathogens effectively. Given the high prevalence of carbapenem resistance, there is an immediate need to explore novel therapeutic options to improve clinical outcomes for diabetic patients with DFUs.
- 9 January 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (2)
Open AccessPrevalence and Molecular Characterization of Carbapenemase-Producing Multidrug-Resistant Bacteria in Diabetic Foot Ulcer Infections
Background: Diabetic foot ulcers (DFUs) represent severe complications in diabetic patients, often leading to chronic infections and potentially resulting in nontraumatic lower-limb amputations. The increasing incidence of multidrug-resistant (MDR) bacteria in DFUs complicates treatment strategies and worsens patient prognosis. Among these pathogens, carbapenemase-producing pathogens have emerged as particularly concerning owing to their resistance to β-lactam antibiotics, including carbapenems. Methods: This study evaluated the prevalence of MDR bacteria, specifically carbapenemase-producing pathogens, in DFU infections. A total of 200 clinical isolates from DFU patients were analyzed via phenotypic assays, including the modified Hodge test (MHT) and the Carba NP test, alongside molecular techniques to detect carbapenemase-encoding genes (blaKPC, blaNDM, blaVIM, blaIMP, and blaOXA-48). Results: Among the isolates, 51.7% were confirmed to be carbapenemase producers. The key identified pathogens included Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, and Escherichia coli. The most commonly detected carbapenemase genes were blaKPC (27.6%) and blaNDM (24.1%). Carbapenemase-producing isolates presented high resistance to β-lactam antibiotics, whereas non-carbapenemase-producing isolates presented resistance through mechanisms such as porin loss and efflux pumps. Conclusions: The findings of this study highlight the significant burden of MDR infections, particularly carbapenemase-producing organisms, in DFUs. MDR infections were strongly associated with critical clinical parameters, including pyrexia (p = 0.017), recent antibiotic use (p = 0.003), and the severity of infections. Notably, the need for minor amputations was much higher in MDR cases (p < 0.001), as was the need for major amputations (p < 0.001). MDR infections were also strongly associated with polymicrobial infections (p < 0.001). Furthermore, Wagner ulcer grade ≥II was more common in MDR cases (p = 0.002). These results emphasize the urgent need for enhanced microbiological surveillance and the development of tailored antimicrobial strategies to combat MDR pathogens effectively. Given the high prevalence of carbapenem resistance, there is an immediate need to explore novel therapeutic options to improve clinical outcomes for diabetic patients with DFUs.
- 19 April 2024
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 397 (9) , 6275-6297
Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infection
Diabetes’s effects on wound healing present a major treatment challenge and increase the risk of amputation. When traditional therapies fail, new approaches must be investigated. With their submicron size and improved cellular internalisation, nanoparticles present a viable way to improve diabetic wound healing. They are attractive options because of their innate antibacterial qualities, biocompatibility, and biodegradability. Nanoparticles loaded with organic or inorganic compounds, or embedded in biomimetic matrices such as hydrogels, chitosan, and hyaluronic acid, exhibit excellent anti-inflammatory, antibacterial, and antioxidant properties. Drug delivery systems (DDSs)—more precisely, nanodrug delivery systems (NDDSs)—use the advantages of nanotechnology to get around some of the drawbacks of traditional DDSs. Recent developments show how expertly designed nanocarriers can carry a variety of chemicals, transforming the treatment of diabetic wounds. Biomaterials that deliver customised medications to the wound microenvironment demonstrate potential. Delivery techniques for nanomedicines become more potent than ever, overcoming conventional constraints. Therapeutics for diabetes-induced non-healing wounds are entering a revolutionary era thanks to precisely calibrated nanocarriers that effectively distribute chemicals. This review highlights the therapeutic potential of nanoparticles and outlines the multifunctional nanoparticles of the future that will be used for complete wound healing in diabetics. The investigation of novel nanodrug delivery systems has the potential to revolutionise diabetic wound therapy and provide hope for more efficient and focused therapeutic approaches.
- 19 April 2024
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 397 (9) , 6275-6297
Narrative review on nanoparticles based on current evidence: therapeutic agents for diabetic foot infection
Diabetes’s effects on wound healing present a major treatment challenge and increase the risk of amputation. When traditional therapies fail, new approaches must be investigated. With their submicron size and improved cellular internalisation, nanoparticles present a viable way to improve diabetic wound healing. They are attractive options because of their innate antibacterial qualities, biocompatibility, and biodegradability. Nanoparticles loaded with organic or inorganic compounds, or embedded in biomimetic matrices such as hydrogels, chitosan, and hyaluronic acid, exhibit excellent anti-inflammatory, antibacterial, and antioxidant properties. Drug delivery systems (DDSs)—more precisely, nanodrug delivery systems (NDDSs)—use the advantages of nanotechnology to get around some of the drawbacks of traditional DDSs. Recent developments show how expertly designed nanocarriers can carry a variety of chemicals, transforming the treatment of diabetic wounds. Biomaterials that deliver customised medications to the wound microenvironment demonstrate potential. Delivery techniques for nanomedicines become more potent than ever, overcoming conventional constraints. Therapeutics for diabetes-induced non-healing wounds are entering a revolutionary era thanks to precisely calibrated nanocarriers that effectively distribute chemicals. This review highlights the therapeutic potential of nanoparticles and outlines the multifunctional nanoparticles of the future that will be used for complete wound healing in diabetics. The investigation of novel nanodrug delivery systems has the potential to revolutionise diabetic wound therapy and provide hope for more efficient and focused therapeutic approaches.
- Open Access
- 15 July 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 14 (7) , 995-1012
Advanced glycation end product signaling and metabolic complications: Dietary approach
The prevalence of diabetes mellitus is increasing in resource limited settings. Simultaneously, there has been an increase in the number of novel therapies for the management of diabetes mellitus. However, use of novel antidiabetic therapies is limited because of major market access challenges in resource limited settings. Niching products to those patients with the highest absolute risk for major adverse cardiovascular outcomes, and thus most likely to benefit from the therapy, are less likely to have negative budget impact for funders. To improve access, and reduce morbidity and mortality, requires alignment amongst key stakeholders including patient advocacy groups, health care professional councils, national departments of health, the pharmaceutical industry, treasury and finance departments.
- 15 July 2023
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 14 (7) , 995-1012
Open AccessAdvanced glycation end product signaling and metabolic complications: Dietary approach
The prevalence of diabetes mellitus is increasing in resource limited settings. Simultaneously, there has been an increase in the number of novel therapies for the management of diabetes mellitus. However, use of novel antidiabetic therapies is limited because of major market access challenges in resource limited settings. Niching products to those patients with the highest absolute risk for major adverse cardiovascular outcomes, and thus most likely to benefit from the therapy, are less likely to have negative budget impact for funders. To improve access, and reduce morbidity and mortality, requires alignment amongst key stakeholders including patient advocacy groups, health care professional councils, national departments of health, the pharmaceutical industry, treasury and finance departments.
- 20 June 2023
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 39 (2) , 257-263
Hesperidin Supplementation Improves Altered PON -1, LDL Oxidation, Inflammatory Response and Hepatic Function in an Experimental Rat Model of Hyperlipidemia
In this study, we have examined the effect of hesperidin on rats fed on an experimental high-fat diet. Male Wistar rats were given a high-fat diet orally for one month for developing an HFD (High fat- diet) model. Rats were also supplemented with hesperidin (100 mg/kg body weight) for one month. We determined serum LDL (Low-density lipoprotein) oxidation, Paraoxonase-1 (PON-1) activity, and histopathological profile of the liver. Inflammatory cytokines levels were also measured in serum. HFD induced significant changes in LDL oxidation and PON-1 activity. Liver tissue histopathology and gene expression of inflammatory markers (Il-6(Interleukin-6), TNF- alpha (Tumor necrosis factor alpha), NF-KB (Nuclear factor kappa B) show that significant changes occur in the hyperlipidemic model of rats. We also show that hesperidin can effectively improve plasma antioxidant, LDL oxidation, and inflammatory cytokine expression in rats already subjected to hyperlipidemic stress. We conclude that hesperidin may protect the liver from oxidative stress by improving hepatic function.
- 20 June 2023
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 39 (2) , 257-263
Hesperidin Supplementation Improves Altered PON -1, LDL Oxidation, Inflammatory Response and Hepatic Function in an Experimental Rat Model of Hyperlipidemia
In this study, we have examined the effect of hesperidin on rats fed on an experimental high-fat diet. Male Wistar rats were given a high-fat diet orally for one month for developing an HFD (High fat- diet) model. Rats were also supplemented with hesperidin (100 mg/kg body weight) for one month. We determined serum LDL (Low-density lipoprotein) oxidation, Paraoxonase-1 (PON-1) activity, and histopathological profile of the liver. Inflammatory cytokines levels were also measured in serum. HFD induced significant changes in LDL oxidation and PON-1 activity. Liver tissue histopathology and gene expression of inflammatory markers (Il-6(Interleukin-6), TNF- alpha (Tumor necrosis factor alpha), NF-KB (Nuclear factor kappa B) show that significant changes occur in the hyperlipidemic model of rats. We also show that hesperidin can effectively improve plasma antioxidant, LDL oxidation, and inflammatory cytokine expression in rats already subjected to hyperlipidemic stress. We conclude that hesperidin may protect the liver from oxidative stress by improving hepatic function.
- Open Access
- 15 March 2023
- Published by Lahore Medical and Dental College
- Vol. 17 (2) , 817-819
Impact of Evaluation of Tumour Grade by Core Needle Biopsy on Clinical Risk Assessment and Patient Selection for Adjuvant Systemic Treatment in Breast Cancer
Introduction: Breast cancer is one of the most common cancers affecting women worldwide. The prognosis and treatment of breast cancer depend largely on various prognostic factors, including tumour grade, hormone receptor status, and HER2/neu overexpression. Objectives: The main objective of the study is to find the impact of evaluation of tumour grade by core needle biopsy on clinical risk assessment and patient selection for adjuvant systemic treatment in breast cancer Material and Methods: This retrospective cohort study was conducted in Services Hospital, Lahore during January 2020 to January 2021. The study participants were women with breast cancer who underwent core needle biopsy for tumour grade evaluation at a single institution during the study period. Results: Of the 70 patients included in the study, the mean age was 58 years (range, 32-85 years), and the majority were postmenopausal (60%). Most patients had invasive ductal carcinoma (IDC) (85%), and the remainder had invasive lobular carcinoma (ILC) (15%). Most patients had stage II (45%) or stage III (35%) breast cancer at the time of diagnosis. All patients underwent core needle biopsy for tumour grade evaluation. Conclusion: In conclusion, the study supports the use of core needle biopsy as a reliable method for evaluating tumour grade in breast cancer patients. Further research is needed to evaluate the long-term outcomes of patients who are treated based on tumour grade assessed by core needle biopsy.
- 15 March 2023
- Published by Lahore Medical and Dental College
- Vol. 17 (2) , 817-819
Open AccessImpact of Evaluation of Tumour Grade by Core Needle Biopsy on Clinical Risk Assessment and Patient Selection for Adjuvant Systemic Treatment in Breast Cancer
Introduction: Breast cancer is one of the most common cancers affecting women worldwide. The prognosis and treatment of breast cancer depend largely on various prognostic factors, including tumour grade, hormone receptor status, and HER2/neu overexpression. Objectives: The main objective of the study is to find the impact of evaluation of tumour grade by core needle biopsy on clinical risk assessment and patient selection for adjuvant systemic treatment in breast cancer Material and Methods: This retrospective cohort study was conducted in Services Hospital, Lahore during January 2020 to January 2021. The study participants were women with breast cancer who underwent core needle biopsy for tumour grade evaluation at a single institution during the study period. Results: Of the 70 patients included in the study, the mean age was 58 years (range, 32-85 years), and the majority were postmenopausal (60%). Most patients had invasive ductal carcinoma (IDC) (85%), and the remainder had invasive lobular carcinoma (ILC) (15%). Most patients had stage II (45%) or stage III (35%) breast cancer at the time of diagnosis. All patients underwent core needle biopsy for tumour grade evaluation. Conclusion: In conclusion, the study supports the use of core needle biopsy as a reliable method for evaluating tumour grade in breast cancer patients. Further research is needed to evaluate the long-term outcomes of patients who are treated based on tumour grade assessed by core needle biopsy.
- 14 March 2023
- Published by Sciencedomain International
- p. 59-66
Role of Vitamins and Nutrition in Old Age as Immune Modulator with Future Prospective
Old age is best defined as age of retirement that is 60 years and above. Nutrition for old age is known as Geriatric Nutrition. Aging brings physiological, psychological and immunological changes which influence the nutritional status. Use of health food and Anti oxidant like Vitamin D, C and E can help the body immune response against Virus.Present Dementia and CVD may share risk factors like high intake of dietary total fat. Emphasis should be placed on reducing the intake of saturated fat and choosing mono saturated or poly saturated fat sources. Sufficient intake of ?-3 fatty acids helps in visual acuity, hair loss, tissue inflammation, improper digestion, poor kidney function and mental depression. Study discuss the role of these vitamin to for Host immune against aging. Due to decrease appetite and poor digestion, old people consume less protein which may lead to edema, anemia, and low resistance to infections. According to data from acute hospitalization studies of older persons, up to 71% are nutritionally vulnerable or malnourished, that’s increased their mortality risk.
- 14 March 2023
- Published by Sciencedomain International
- p. 59-66
Role of Vitamins and Nutrition in Old Age as Immune Modulator with Future Prospective
Old age is best defined as age of retirement that is 60 years and above. Nutrition for old age is known as Geriatric Nutrition. Aging brings physiological, psychological and immunological changes which influence the nutritional status. Use of health food and Anti oxidant like Vitamin D, C and E can help the body immune response against Virus.Present Dementia and CVD may share risk factors like high intake of dietary total fat. Emphasis should be placed on reducing the intake of saturated fat and choosing mono saturated or poly saturated fat sources. Sufficient intake of ?-3 fatty acids helps in visual acuity, hair loss, tissue inflammation, improper digestion, poor kidney function and mental depression. Study discuss the role of these vitamin to for Host immune against aging. Due to decrease appetite and poor digestion, old people consume less protein which may lead to edema, anemia, and low resistance to infections. According to data from acute hospitalization studies of older persons, up to 71% are nutritionally vulnerable or malnourished, that’s increased their mortality risk.
- 5 February 2023
- Published by Discovery Scientific Society in Medical Science
- Vol. 27 (132) , 1-8
"Assessment of knowledge and practice of Carpal tunnel syndrome among pregnant and non-pregnant women in Hail region, Saudi Arabia"
- 5 February 2023
- Published by Discovery Scientific Society in Medical Science
- Vol. 27 (132) , 1-8
"Assessment of knowledge and practice of Carpal tunnel syndrome among pregnant and non-pregnant women in Hail region, Saudi Arabia"